BERGAGGIO, ELISA
 Distribuzione geografica
Continente #
EU - Europa 229
NA - Nord America 193
AS - Asia 138
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 563
Nazione #
US - Stati Uniti d'America 191
IT - Italia 145
CN - Cina 88
RU - Federazione Russa 17
FR - Francia 15
KR - Corea 11
DE - Germania 10
CZ - Repubblica Ceca 8
JP - Giappone 7
TW - Taiwan 7
IN - India 6
IR - Iran 6
PL - Polonia 6
AT - Austria 5
ES - Italia 4
GB - Regno Unito 4
IL - Israele 4
CH - Svizzera 3
GR - Grecia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
VN - Vietnam 3
CU - Cuba 2
HK - Hong Kong 2
RO - Romania 2
SE - Svezia 2
A1 - Anonimo 1
BR - Brasile 1
FI - Finlandia 1
HU - Ungheria 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 563
Città #
Torino 64
Turin 22
Woodbridge 21
Fairfield 20
Novara 17
Volzhskiy 13
Santa Cruz 12
Ashburn 11
Cambridge 10
Houston 9
Seattle 9
Shanghai 8
Beijing 7
Buffalo 7
Wilmington 7
Xian 7
Guangzhou 6
Seoul 6
Ann Arbor 5
Nanjing 5
Vienna 5
Tehran 4
Ashquelon 3
Athens 3
Hefei 3
Kansas City 3
Suzhou 3
Taipei 3
Valdagno 3
Zhengzhou 3
Baotou 2
Caselle Torinese 2
Changsha 2
Chapel Hill 2
Council Bluffs 2
Dallas 2
Dong Ket 2
Grugliasco 2
La Habana 2
Las Vegas 2
Latina 2
Los Angeles 2
Malden 2
Napoli 2
Palermo 2
Redmond 2
Salamanca 2
San Diego 2
Shenzhen 2
Silchar 2
University Park 2
Alcamo 1
Ascoli Piceno 1
Beckley 1
Bellinzona 1
Bengaluru 1
Boston 1
Castelnuovo Di Garfagnana 1
Central District 1
Chennai 1
Cincinnati 1
Clearwater 1
Duncan 1
Durham 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Gainesville 1
Galati 1
Geneve 1
Hanoi 1
Heidelberg 1
Herndon 1
Hillsborough 1
Ilk 1
Istanbul 1
Jacksonville 1
Kish 1
Lake Forest 1
Lausanne 1
Minneapolis 1
Mountain View 1
Muizenberg 1
Munich 1
New Haven 1
Norristown 1
Nürnberg 1
Pentre 1
Phoenix 1
Ramona 1
Richmond 1
Rochester 1
Rome 1
Saint Louis 1
Santa Barbara 1
Santa Clara 1
Shenyang 1
São Paulo 1
Tokyo 1
Ulan-ude 1
Totale 390
Nome #
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies, file e27ce42d-6147-2581-e053-d805fe0acbaa 253
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies, file e27ce42d-6146-2581-e053-d805fe0acbaa 217
Wild-type idh enzymes as actionable targets for cancer therapy, file e27ce430-c0a2-2581-e053-d805fe0acbaa 58
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer, file 1a1fc490-ba73-4ca1-ba49-11eee6626108 20
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts, file e27ce42b-e85e-2581-e053-d805fe0acbaa 20
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies, file e27ce432-4e11-2581-e053-d805fe0acbaa 8
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells, file 0196205f-45e5-4f92-9089-2f07841f22a5 4
Biomimetic mesoporous vectors enabling the efficient inhibition of wild-type isocitrate dehydrogenase in multiple myeloma cells, file 5e4e1830-0ccd-453a-8494-6635643bba7a 2
Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma, file 88846a61-d7f0-4874-bfd0-24297cd7cdb3 2
Totale 584
Categoria #
all - tutte 798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 0 9 3
2019/2020125 0 2 1 3 8 8 17 13 18 29 18 8
2020/2021166 5 18 9 3 23 29 12 12 9 19 11 16
2021/2022100 9 16 13 2 4 4 6 3 15 6 16 6
2022/202359 2 3 12 11 12 4 3 3 5 4 0 0
2023/202428 0 0 0 0 0 0 0 4 5 19 0 0
Totale 584